Cargando…
Inhibition of Stat3‐mediated astrogliosis ameliorates pathology in an Alzheimer's disease model
Reactive astrogliosis is a hallmark of Alzheimer's disease (AD), but its role for disease initiation and progression has remained incompletely understood. We here show that the transcription factor Stat3 (signal transducer and activator of transcription 3), a canonical inducer of astrogliosis,...
Autores principales: | Reichenbach, Nicole, Delekate, Andrea, Plescher, Monika, Schmitt, Franziska, Krauss, Sybille, Blank, Nelli, Halle, Annett, Petzold, Gabor C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365929/ https://www.ncbi.nlm.nih.gov/pubmed/30617153 http://dx.doi.org/10.15252/emmm.201809665 |
Ejemplares similares
-
P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer’s disease model
por: Reichenbach, Nicole, et al.
Publicado: (2018) -
Slc1a3-2A-CreERT2 mice reveal unique features of Bergmann glia and augment a growing collection of Cre drivers and effectors in the 129S4 genetic background
por: Kaczmarczyk, Lech, et al.
Publicado: (2021) -
Neuritin inhibits astrogliosis to ameliorate diabetic cognitive dysfunction
por: Zhang, Zuo, et al.
Publicado: (2021) -
NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
por: Heneka, Michael T., et al.
Publicado: (2012) -
Pregabalin improves axon regeneration and motor outcome in a rodent stroke model
por: Kugler, Christof, et al.
Publicado: (2022)